Industry
Featured experience
Endo $6.7 billion merger with Mallinckrodt
We are advising Endo on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Charles River Laboratories cooperation agreement with Elliott
We are advising Charles River on the agreement
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Ionis Pharmaceuticals $770 million convertible senior notes offering
We advised the representatives of the initial purchasers on the offering
GRAIL $300 million at-the-market offering
We advised the sales agents on the offering
Novartis $6 billion notes offering
We advised Novartis on the investment-grade debt offering
Novanta $632.5 million tangible equity units offering
We advised the representatives of the several underwriters on the offering
Bristol Myers Squibb €5 billion notes offering
We advised the underwriters on Bristol Myers Squibb Ireland’s inaugural euro issuance
Auna $400 million refinancing
We advised Auna on the transaction
Auna $365 million senior secured notes offering and cash tender offer
We advised Auna on the offering
Inventiva $100 million at-the-market offering
The American depository shares are listed on Nasdaq
Ardelyx $100 million at-the-market offering
The shares are listed on the Nasdaq Global Market
Oculis Holding $110 million concurrent stock offerings
The shares are listed on the Nasdaq Global Market and the Nasdaq Iceland Main Market